Abstract
Challenges of Antiviral Therapy on Clinical Outcomes and 30-Day Survival Benefits in Hospitalized Multiple Sclerosis Patients with COVID-19
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have